Company / Working Capital
CHAMPIONS ONCOLOGY, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$1.5M
FY2025
5-year range
-$7.9M / $2.2M
FY2021-FY2025
Trend
+81.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital returned to growth in FY2025 after 2 years of decline, reaching -$1M.
Based on SEC 10-K filings.
-$1M in FY2025.
Improved from -$2M to -$1M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital increased 81.2% year-over-year.
- Peak working capital was recorded in FY2022.
- Lowest working capital in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.5M | +81.2% |
| FY2024 | -$7.9M | -247.2% |
| FY2023 | -$2.3M | -204.2% |
| FY2022 | $2.2M | +52.7% |
| FY2021 | $1.4M | +19.9% |
| FY2020 | $1.2M | +1258.3% |
| FY2019 | -$103.0K | +95.7% |
| FY2018 | -$2.4M | -51.6% |
| FY2017 | -$1.6M | -63.4% |
| FY2016 | -$966.0K | -113.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026